Placebo-Driven Clinical Trials of Transfer Point Glucan #300 in Children with Chronic Respiratory Problems: Antibody Production
Vetvicka Vaclav1, Richter Josef2, Svozil Vladimir3, Rajnohova Dobiasova Lucie2 & Kral Vlastimil2 Show affiliations
- University of Louisville, United States
- Regional Institute of Public Health, Ústí nad Labem, Czech Republic
- Sanatorium Edel, Zlaté Hory, Czech Republic
American Journal of Immunology, Volume 9, Issue 2, pp. 43–47 · doi.org/10.3844/ajisp.2013.43.47
Abstract
The role of glucan in stimulation of immune reactions has been well-established. In this report, we focused on the antibody production in glucan-supplemented children with chronic respiratory problems. We measured the levels of salivary IgA, IgM and IgG in 40 children aged 8-12 years and evaluated the effects of 100 mg d-1 oral dose of glucan. We found a significant increase in production of all tested antibodies in the glucan-stimulated group, but a decrease of antibody production in the control group. A thirty-day oral application of yeast-based natural immunomodulator β-glucan strongly stimulated the mucosal immunity of children with chronic respiratory problems.
Licence and reuse
Free to read. This article carries the publisher’s copyright, as printed on it: © 2013 Science Publications. It is free to read; ask us before reusing it.
How to reuse this articleResponses (0)
About this article
Vaclav, V., Josef, R., Vladimir, S., Lucie, R. D. & Vlastimil, K. (2013). Placebo-Driven Clinical Trials of Transfer Point Glucan #300 in Children with Chronic Respiratory Problems: Antibody Production. American Journal of Immunology, 9(2), 43–47. https://doi.org/10.3844/ajisp.2013.43.47
- Licence
- © Science Publications
- Issue
- Volume 9, Issue 2
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record